Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIGG: Gentamicin for Suppurated Cat Scratch Disease's Lymphadenitis
NCT03132116Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2017
- Primary completion
- Aug 2025
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cat scratch disease (CSD) comparing Gentamicin with Placebo (2 arms). Primary endpoint: Frequency of CSD's adenitis favorable outcome at 28 days. Started May 2017; status: completed.
02
Drugs
gentamicin
03
Conditions
cat scratch disease (CSD)
Beyond the preview
Go deeper on NCT03132116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03132116.